These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37733090)

  • 1. Re: Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes. World J Urol. 2023 Jul 28. doi: 10.1007/s00345-023-04536-3.
    Ghoreifi A; Djaladat H
    World J Urol; 2023 Nov; 41(11):3385-3386. PubMed ID: 37733090
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Lloyd P, Hong A, Furrer MA, et al. A comparative study of perioperative outcomes for 100 consecutive post-chemotherapy and primary robot assisted and open retroperitoneal lymph node dissections. World J Urol. 2021; DOI: 10.1007/s00345-021-03832-0.
    Ghoreifi A; Djaladat H
    World J Urol; 2022 May; 40(5):1243-1244. PubMed ID: 35064295
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes.
    Branger N; Bladou F; Verhoest G; Knipper S; Robert G; Bernhard JC; Beauval JB; Khaddad A; Mauger De Varennes A; Fléchon A; Walz J; Bageot AS; Doumerc N; Rouprêt M; Murez T;
    World J Urol; 2023 Sep; 41(9):2405-2411. PubMed ID: 37507528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
    Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
    J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ejaculatory function in stage T1 nonseminomatous germ cell tumors: retroperitoneal lymph node dissection versus surveillance--a decision analysis.
    Langenstroer P; Rosen MA; Griebling TL; Thrasher JB
    J Urol; 2002 Oct; 168(4 Pt 1):1396-401. PubMed ID: 12352401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: The Impact of Bleomycin on Retroperitoneal Histology at Post-Chemotherapy Retroperitoneal Lymph Node Dissection of Good Risk Germ Cell Tumors: K. C. Cary, J. A. Pedrosa, H. Z. Kaimakliotis, T. A. Masterson, L. H. Einhorn and R. S. Foster J Urol 2015;193:507-512.
    Verma A; Giri V; Priyadarshi S
    J Urol; 2015 Jul; 194(1):266; author reply 266. PubMed ID: 25857530
    [No Abstract]   [Full Text] [Related]  

  • 7. Robot-assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes.
    Garg H; Mansour AM; Psutka SP; Kim SP; Porter J; Gaspard CS; Dursun F; Pruthi DK; Wang H; Kaushik D
    BJU Int; 2023 Jul; 132(1):9-30. PubMed ID: 36754376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.
    Clevenger JA; Foster RS; Ulbright TM
    Mod Pathol; 2009 Oct; 22(10):1361-6. PubMed ID: 19633644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
    Ghoreifi A; Djaladat H
    Eur Urol; 2023 Jan; 83(1):e18-e19. PubMed ID: 36195480
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
    Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
    World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desperation Postchemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors.
    Carver BS
    Urol Clin North Am; 2015 Aug; 42(3):343-6. PubMed ID: 26216821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Axel Heidenreich, David Thüer, Sergej Polyakov. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Eur Urol 2008;53:260-74.
    Vergouwe Y; Steyerberg EW
    Eur Urol; 2008 Oct; 54(4):954-5. PubMed ID: 18572303
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer.
    Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
    Urol Oncol; 2005; 23(6):423-30. PubMed ID: 16301122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Postchemotherapy Surgery in Germ Cell Tumors.
    Chéry L; Dash A
    Urol Clin North Am; 2015 Aug; 42(3):331-42. PubMed ID: 26216820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
    Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort.
    Taylor J; Becher E; Wysock JS; Lenis AT; Litwin MS; Jipp J; Langenstroer P; Johnson S; Bjurlin MA; Tan HJ; Lane BR; Huang WC
    Eur Urol Focus; 2021 Nov; 7(6):1403-1408. PubMed ID: 32682794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.